A detailed history of Red Spruce Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Red Spruce Capital, LLC holds 39,440 shares of MRK stock, worth $3.91 Million. This represents 2.11% of its overall portfolio holdings.

Number of Shares
39,440
Previous 39,599 0.4%
Holding current value
$3.91 Million
Previous $4.9 Million 8.65%
% of portfolio
2.11%
Previous 2.35%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$111.15 - $128.97 $17,672 - $20,506
-159 Reduced 0.4%
39,440 $4.48 Million
Q2 2024

Jul 02, 2024

BUY
$123.8 - $132.96 $54,224 - $58,236
438 Added 1.12%
39,599 $4.9 Million
Q1 2024

Apr 10, 2024

BUY
$113.24 - $131.95 $15,740 - $18,341
139 Added 0.36%
39,161 $5.17 Million
Q4 2023

Jan 05, 2024

BUY
$100.18 - $109.02 $62,211 - $67,701
621 Added 1.62%
39,022 $4.25 Million
Q3 2023

Oct 03, 2023

BUY
$102.95 - $114.33 $1,647 - $1,829
16 Added 0.04%
38,401 $3.95 Million
Q2 2023

Jul 05, 2023

SELL
$108.61 - $118.38 $1.51 Million - $1.64 Million
-13,875 Reduced 26.55%
38,385 $4.43 Million
Q1 2023

Apr 06, 2023

BUY
$102.94 - $114.86 $87,190 - $97,286
847 Added 1.65%
52,260 $5.56 Million
Q4 2022

Jan 03, 2023

BUY
$87.44 - $112.11 $72,750 - $93,275
832 Added 1.64%
51,413 $0
Q3 2022

Oct 03, 2022

SELL
$84.53 - $94.96 $238,036 - $267,407
-2,816 Reduced 5.27%
50,581 $4.36 Million
Q2 2022

Jul 05, 2022

SELL
$83.49 - $94.64 $31,809 - $36,057
-381 Reduced 0.71%
53,397 $4.87 Million
Q1 2022

Apr 05, 2022

BUY
$73.51 - $82.4 $146,358 - $164,058
1,991 Added 3.84%
53,778 $4.41 Million
Q4 2021

Jan 03, 2022

BUY
$72.28 - $90.54 $173,110 - $216,843
2,395 Added 4.85%
51,787 $3.97 Million
Q3 2021

Oct 04, 2021

BUY
$71.68 - $78.83 $263,137 - $289,384
3,671 Added 8.03%
49,392 $3.71 Million
Q2 2021

Jul 06, 2021

BUY
$70.31 - $77.77 $130,565 - $144,418
1,857 Added 4.23%
45,721 $3.56 Million
Q1 2021

Apr 01, 2021

BUY
$68.86 - $81.11 $313,519 - $369,293
4,553 Added 11.58%
43,864 $3.38 Million
Q4 2020

Jan 04, 2021

BUY
$71.77 - $79.65 $51,602 - $57,268
719 Added 1.86%
39,311 $3.22 Million
Q3 2020

Oct 02, 2020

SELL
$73.18 - $82.95 $10,025 - $11,364
-137 Reduced 0.35%
38,592 $3.2 Million
Q2 2020

Jul 02, 2020

BUY
$70.42 - $80.13 $1.49 Million - $1.69 Million
21,117 Added 119.9%
38,729 $3 Million
Q1 2020

Apr 06, 2020

BUY
$63.36 - $87.82 $17,740 - $24,589
280 Added 1.62%
17,612 $1.36 Million
Q4 2019

Jan 16, 2020

BUY
$77.58 - $87.54 $1.34 Million - $1.52 Million
17,332 New
17,332 $1.58 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Red Spruce Capital, LLC Portfolio

Follow Red Spruce Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Spruce Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Spruce Capital, LLC with notifications on news.